#mri cmc

[mirag8515]

"How 1.5T MRI Elevates Patient Care Standards"

Today, 1.5 Tesla (1.5T) MRI is the most common imaging system used all over the world, primarily because of the image quality and operational efficiency it possesses. The "1.5T" indicates the strength of the magnetic field produced by it.. This strength is sufficient to provide some very clear and precise images of the internal body structures formed by pathology, especially in terms of diagnosis, and used from the neurological point of view up to the musculoskeletal injuries.

1.5T MRIs are very versatile because they have that high clarity image and can easily perform different types of scans, both in the brain and spinal regions and within the cardiac imaging field. In addition, faster than the higher-strength machines are scan times that make them suitable for patient-friendliness. Less noise and increased imaging combination offer patient comfort while not compromising diagnostic precision with a 1.5T MRI.

At CMED, we provide advanced 1.5T MRI machines considering the modern requirement of medical practice and spaces. Reliability and innovation have come together in these cost-efficient machines to allow healthcare professionals to offer the highest standards in diagnostic care. Take a look at our MRIs and lift your diagnostic accuracy to the next level.

[phantomhealthcare]

Going Global And Beyond

We are taking the initiative to go global with state-of-the-art refurbished imaging equipment and services. Here we buy and sell modern equipment like MRI machines, Cath Lab machines, and Pet CT machines. Apart from this, we also provide AMC / CMC service and parts.

Join us and unlock the limitless possibilities in medical imaging technology, get the many benefits

✔️Warranty of Equipment & Spare Parts ✔️Customer Support ✔️Site Planning ✔️Financial Assistance ✔️Quality Assurance ✔️Sustainability

[healthcareanna]

Contrast Media Market Size, Trends, Growth Forecast 2032

Contrast Media Market Overview

Market Research Future (MRFR) predicts the Global Contrast Media Market size was valued at USD 6.36 Billion in 2023. The Global Contrast Media industry is projected to grow from USD 6.74 Billion in 2024 to USD 18.23 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.76% during the forecast period (2024 - 2032). The radiographic contrast agents market is characterized by a dynamic interplay of technological advancements, evolving regulatory landscapes, and growing demand for diagnostic imaging procedures. Radiographic contrast agents, often referred to as contrast media, play a pivotal role in enhancing the visibility of anatomical structures during medical imaging procedures such as X-rays, computed tomography (CT), and fluoroscopy. These agents are formulated to selectively absorb or scatter X-rays, thereby accentuating the contrast between different tissues or organs within the body. As medical imaging technologies continue to advance, there is a corresponding increase in the diversity and efficacy of radiographic contrast agents, driving market growth.

Contrast Media Market Key players

Prominent contrast media companies are

AMAG Pharmaceuticals (US)

Bracco Diagnostic Inc. (Italy)

Lantheus Medical Imaging (U.S.)

Covidien (Ireland)

Mallinckrodt Pharmaceuticals (UK)

Targeson (US)

nanoPET Pharma GmbH (Germany)

NanoScan Imaging (US)

Medrad Inc. (US)

Guerbet Group (France)

Subhra Pharma Private Limited (India)

GE Healthcare (US)

CMC Contrast AB (Sweden)

Daiichi (Japan)

Bayer Healthcare Pharmaceuticals (Germany)

Latest Innovation on Contrast Media Market

Advanced MRI Contrast Agents

Recent innovations in MRI contrast agents include the development of new gadolinium-based compounds with improved safety profiles and enhanced imaging capabilities. These advanced agents offer higher resolution images and better tissue differentiation, which can lead to more accurate diagnostics and reduced need for follow-up imaging.

Hybrid Contrast Agents for Multimodal Imaging

New hybrid contrast agents are being developed to work across multiple imaging modalities, such as MRI, CT, and ultrasound. These agents provide versatility and improved diagnostic accuracy by allowing for comprehensive imaging assessments with a single contrast medium, reducing patient exposure to multiple agents and optimizing workflow efficiency.

Iodinated contrast media are widely used in radiographic imaging studies such as computed tomography (CT) scans and angiography. These contrast agents contain iodine, which has a high atomic number and excellent X-ray attenuation properties, making it ideal for enhancing contrast in X-ray images. Iodinated contrast media are administered orally, intravenously, or rectally, depending on the imaging modality and the area of the body being examined.

Contrast Media Market Segmentation

The segmental study of the Global Contrast Media Market gives a compendious market overview that highlights key points of the market that benefits our clients to identify growth opportunities of the market. The contrast media market study is segmented into type, procedure, application, and route of application.

Based on the type, the market is segmented into intravenous contrast materials, iodine-based contrast media agents, and others.

Based on the application, the market is segmented into nephrological disorders, oncology, cardiovascular disorders, and others.

Based on the route of administration, the market is segmented into injectable, rectal, and oral.

Gadolinium-based contrast agents are commonly used in magnetic resonance imaging (MRI) studies to improve image contrast and delineate structures with greater clarity. These contrast agents contain gadolinium, a paramagnetic metal that alters the magnetic properties of tissues and enhances signal intensity on MRI images.

Contrast Media Market Regional Insights

MRFR’s regional analysis of the Contrast Media Market gives a holistic approach towards the demographic progress of the market in the forecast years. Based on the region, the contrast media market is segmented into Asia Pacific, North America, Europe, and the Rest-of-the-World (RoW).

North America is expected to dominate the market, holding a significant market share owing to its strong technological infrastructure. Increase in medical tourism, rise in the number of cancer patients and patients suffering from chronic disorders, and market players likely to deliver cost-competitive contrast media products are factors which are predicted to fuel the regional market growth.  

Robust economic improvement, existence of influential market players, and technological advancements in the European region can augment the regional market proliferation.

The contrast media market in the Asia Pacific region, led by the rapidly proliferating healthcare sector and developing economy, has emerged as a promising market, globally. Increasing markets in countries, such as Japan, China, and India, are pushing up the growth in the regional market. Moreover, the APAC Contrast Media Market is driven by the rising population and the spreading awareness towards the functionalities of contrast media.

The rapidly growing healthcare industry and emerging economies like India, Japan, and China in the Asia Pacific region, a huge population, and increase in awareness towards benefits of contrast media are market dynamics expected to drive the regional market growth.

Browse Related Reports-

Blood Glucose Monitoring market

Syringe and Needle market

Dental Implants market

Stem Cell Manufacturing market

Automatic Pill Dispenser market

[market-research-repoert]

Industry analysis provides a company with an understanding of its position relative to other companies in the industry. This can help them identify opportunities and potential threats, so they can prepare for the present and future. MRI Research helps organizations to figure out whats happening in a given industry, including demand and supply statistics, degree of competition, state of competition with other emerging industries, future prospects considering technological changes, and external factors on the industry.

[mochimaster]

Alrighty update on my dad, it's a tad bit lengthy but bare with me here:

So after they moved him to CMC Union (the bigger hospital) they found out that the hernia wasn't actually ruptured but just severely infected with mass amounts of fluid behind his abdominal wall. That's better than it being ruptured, it's still like picking a lesser of two evils but we'll take infection over internal hemorrhaging any day.

But here comes the complicated and scary part. Years ago my dad suffered with liver disease a long time due to his heavy alcoholic past, after the drug Harvoni came out he took it and cleared the Hep C no problem.

Welp they checked his liver since he has a history of liver disease and turns out they found two nice sized lumps on his liver. Now he does have a lot scar tissue thanks to years of drink and drug use in his younger days and just from living with Hep C for so long but these lumps don't look like normal scar tissue.

We're just hoping that's it's mild cirrhosis of the liver that's visible via CT and MRI or benign tumors. If we're lucky it's just random lumps but they can't take any risks because of his age (58) and health history.

[martynnx-blog]

Contrast Media/Contrast Agent Market Stand Out As The Biggest Contributor To Global Growth 2018-2026

Contrast media or contrast agent is used in medical imaging to enhance the image of body parts generated through X-rays, magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound. These substances are momentarily used to change the way imaging tools or x-rays interact with the body. Contrast media or contrast agent help the physicians to diagnose the medical conditions by improving the visibility of blood vessels or tissues and specific organs. These substances are added into the body prior to an imaging scan to help distinguish certain structures or tissues of interest from the surrounding tissue. Contrast media or contrast agent can be administered into the body in one of the four ways which include by enema (given rectally), orally, urethral, and by injecting into a blood vessel.

Download PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1210

Rise in the gas micro bubble technology in MRI imaging is expected to boost the growth of contrast media/contrast agent market

The major factors driving the growth of contrast Media/contrast agent are the use of advanced technology such as gas micro bubble technology in MRI imaging, rising incidence of chronic diseases such as cardiac diseases, gastrointestinal disorders, and cancer. Advancements in medical imaging technology and increasing demand for image guided procedures and diagnostics is fueling the growth of the market. According to the International Agency for Research on Cancer (IARC), in 2012, an estimated 14.1 million new cancer cases and 8.2 million cancer deaths were recorded worldwide and by 2030 the number is expected to escalate to 21.7 million for new cancer cases and 13 million cancer deaths. However, side effects of contrast agents such as kidney diseases and high cost associated with the contrast media injectors are some of the factors that are hindering the growth of contrast media/ contrast agent market.

Increasing incidence of cancer and cardiac disorders is expected to dominate North America region in contrast media/contrast agent market

On the basis of region, the global contrast media/contrast agent market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America dominates the contrast media/ contrast agent in the global market, followed by Europe. Improved MRI techniques in cardiovascular diseases, rise in the number of cancer and cardiac disorders, advancements in diagnostic technology, image guided surgical procedures are the factors that has propelled the growth of contrast media/contrast agent market in the North America region. According to the National Cancer Institute, in 2016, an estimated 1,685,210 new cases of cancer were diagnosed in the U.S. Also, according to the Centers for Disease Control and Prevention (CDC), 2017, an estimated 28.4 million heart cases were diagnosed in the U.S.

Key players operating in the market

In March, 2017, GE Healthcare has launched Clariscan, a gadolinium based contrast agent designed to support effective visualization of abnormalities in the spine, brain and associated tissues. Clariscan, also known to be a gold standard detection tool in MR imaging, allows prompt detection of abnormalities by helping in improving contrast between pathological and normal tissue.

The key players operating in the contrast media/contrast agent market include Lantheus Medical Imaging, GE Healthcare, Bayer HealthCare, Bracco Imaging S.p.A, NanoPET Pharma GmbH, Guerbet Group, CMC Contrast AB, Daiichi Sankyo, and Subhra Pharma Private Limited.

Browse Complete Report For More Information @ https://www.coherentmarketinsights.com/ongoing-insight/contrast-media-contrast-agent-market-1210

[sapanas]

Contrast Media Market 2025 Forecasts By Global Industry Analysis In 2020 Report

Based on data by Market Research Future this report on ‘Contrast Media Market’ delivers a succinct analysis on industry size, regional growth and revenue forecasts for the upcoming years. The report further sheds light on significant challenges and latest growth strategies adopted by manufacturers who are a part of the competitive spectrum of this business domain.

Contrast Media Market Overview

Contrast Media is a substrate used during medical imaging to enhance the contrast of fluids in the body, basically to enhance the visibility of blood vessels and GI tract. Over the past couple of years, contrast media has evolved dramatically, making phenomenal headways in terms of product developments and their approvals. This, as a result, has helped the market to garner exponential traction, worldwide, addressing the augmented demand and meeting the expectations of patients and radiologists, simultaneously.

Acknowledging the exponential growth, the market perceives currently, Market Research Future (MRFR), in its recently published study report asserts that the global contrast media market will further create a substantial revenue pocket by 2023, registering approximately 6.3% CAGR throughout the forecast period (2017 – 2023). The increasing number of approvals for contrast agents are positively impacting the market.

Read more news on: https://www.medgadget.com/2020/06/covid-19-outbreak-impact-on-contrast-media-market-2020-global-report-industry-size-share-growth-top-companies-analysis-upcoming-trends.html

Burgeoning healthcare sector, technological advancements in medical imaging technology and techniques are some of the key driving forces behind the growth of the market. These advancements have introduced improved utilization of most of the existing contrast media agents while presenting the innovative agents.

Besides, factors such as the rising prevalence of various chronic diseases such as GIT, Cancer, Cardiac diseases and increase in the number of public as well as private diagnostic centers to improve diagnostic imaging services are fostering the demand for various diagnostic imaging modalities.

On the flip side, factors such as the risk of side / adverse effects of the contrast media might poses challenges in market growth.  Nevertheless, advantages offered by the technological innovations are expected to support the market growth, by bringing improvements in the functionalities of these media.

Similarly, a robust range of products brought about by the market players by increasing research activities working towards the applications of various contrast agents, are paving the ways for the market growth potential.

Syringeless contrast media injectors are the latest trend of the market owing to their efficacy in minimizing the wastage of media coupled with the and software advancements that bring ease in the use of the devices.

Due to the increased use of off-pump CABG procedures, the risk of AKI with CABG versus PCI is decreasing. This defines the increased use of off-pump CABG procedures, which might be safer for the kidneys.

Global Contrast Media Market – Segments

For enhanced understanding, the report has been segmented into five key dynamics.

By Type                                          : Iodine-based, and Intravenous Contrast Materials among others.

By Procedure                               : X-ray, Computed Tomography, Ultrasound, and Magnetic Resonance Imaging among others.

By Application                             : Oncology, Cardiovascular Disorders, and Nephrological Disorders among others.

By Route of Administration     : Oral, Injectable, and Rectal

By Regions                                    : Asia Pacific, North America, Europe, and the Rest-of-the-World.

Global Contrast Media Market – Geographical Analysis

The North American region, heading with the technological advancements, dominates the global contrast media market with a significant market share.  Moreover, factors such as the increasing prevalence of GI disease and advancements in medical science drive the growth of the regional market.  Similarly, factors such as the huge uptake of advanced technologies and increasing emphasis of market players on delivering cost-competitive contrast media foster the growth of the regional market.

The European contrast media market, backed by improving economic conditions in the region has emerged as another lucrative market, globally.  Additionally, factors such as increasing healthcare expenditures, the adoption of advanced technologies, and the presence of global players foster the growth of the medical supplies market in the region.

The contrast media market in the Asia Pacific region, led by the rapidly proliferating healthcare sector and developing economy, has emerged as a promising market, globally. Increasing markets in countries, such as Japan, China, and India, are pushing up the growth in the regional market. Moreover, the APAC contrast media market is driven by the rising population and the spreading awareness towards the functionalities of contrast media.

Global Contrast Media Market – Competitive Landscape

Fiercely competitive, the contrast media market appears to be fragmented owing to the presence of numerous matured & small players. Matured players try to gain a competitive edge through strategic initiatives such as acquisition, partnership, expansion, collaboration, and product & technology launch. They invest heavily in R&D to develop a manufacturing technique that is entirely on a different level compared to their competition.

Contrast Media Market Major Players:

Key players leading the global contrast media market include Daiichi (Japan), Bayer Healthcare Pharmaceuticals (Germany), GE Healthcare (US), NanoScan Imaging (US), Medrad Inc. (US), Guerbet Group (France), Targeson (US), AMAG Pharmaceuticals (US), Bracco Diagnostic Inc. (Italy), Lantheus Medical Imaging (U.S.), Covidien (Ireland), nanoPET Pharma GmbH (Germany), Subhra Pharma Private Limited (India), CMC Contrast AB (Sweden), and Mallinckrodt Pharmaceuticals (UK) among others.

Contrast Media Industry, Innovation & Related News

February 06, 2019 – Imagion Biosystems Limited (Australia), a leading global company dedicated to improving healthcare through the earlier detection of cancer announced achieving a key milestone in its progress to first-in-human testing with the commencement of a toxicology safety study of its lead nanoparticle formulation for the detection of HER2 metastatic breast cancer. Imagion is developing a new non-radioactive and safe diagnostic imaging technology.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/contrast-media-market-1284

Untargeted iron oxide nanoparticles that have been shown to be bio-safe and are used off-label as an MRI contrast agent, but their lack of specificity has limited their diagnostic utility. Based on recommendations from the U.S. FDA, the Company has engaged a contract research organization to undertake the toxicology study following Good Laboratory Practices (GLP).

December 05, 2018 --- Guerbet (France), a leading global manufacturer of contrast agents launched its multi-use OptiVantage contrast media injector in Europe. At the event, the company also announced that the OptiVantage multi-use contrast media injector which is designed for injecting contrast agents used in computed tomography (CT) scan medical examinations is now CE marked.        

[mirag8515]

CT Scan Machines: A Comprehensive Solution for Imaging Needs

The CT scan machines are the most important equipment in medical diagnosis, since they provide clear and detailed images obtained from internal organs, bones, and tissues. Using the latest in X-ray technology, these machines produce cross-sectional images to help doctors accurately identify fractures, tumors, and internal injuries. These machines are unique for rapidly developing images and make the cut indispensable in emergency departments and general diagnostics.

Modern CT scan machines today have been specially adapted to save time and make patients comfortable. The time of scanning by the machines and radiation exposure are optimized without compromising the accuracy of results. This feature makes the machines appropriate for obtaining diagnostic findings for all medical conditions- from the heart and circulatory system to abnormalities in the brain.

CMED is a one-stop supplier of advanced CT scan machines that suit the unique specifications of health care institutions. CMED guarantees brilliance and innovation within the devices while ensuring that they meet the increasing need for precision in diagnosis and patient care.

[phantomhealthcare]

Choose A Refurbished MRI Machine - Phantom Healthcare

Why Choose Phantom Healthcare for a Refurbished MRI Machine

✅Complete Site Planning and Turnkey Solution ✅Fast & Superior MRI Machine ✅24X7 Response time Guarantee ✅Low Maintenance & Reasonable Price

𝐋𝐞𝐭'𝐬 𝐃𝐢𝐬𝐜𝐮𝐬𝐬 𝐲𝐨𝐮𝐫 𝐑𝐞𝐪𝐮𝐢𝐫𝐞𝐦𝐞𝐧𝐭: 𝟗𝟖𝟗𝟗𝟗𝟔𝟑𝟔𝟎𝟏

[vinayakmrfr1998-blog]

Contrast Media Market Research Report on Regional Insights And Industrial Analysis Till 2025

Global Contrast Media Market Research Report: By Type (Iodinated Contrast Media and Gadolinium-Based Contrast Media), by Form (Tablet, Powder, Liquid and Paste), Procedures (X-ray/Computed Tomography (CT) and Magnetic Resonance Imaging (MRI)), By Application (Cardiovascular Disease, Oncology and Gastrointestinal Disorders), By Route of Administration (Rectal, Oral and Injectable) and Region (the Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2025

 The contrast media/ contrast agents market is making significant strides over recent years, mainly due to the rapidly developing medical imaging technologies. Besides, strong headways in terms of product developments and their approvals drive the growth of the market. The healthcare sector is burgeoning and medical imaging technology & techniques are advancing profusely. These advancements have improved the utilization of the existing contrast media while presenting innovative agents. This, in turn, escalates the market to furthered height. 

According to Market Research Future (MRFR), the global contrast media market size is estimated to increase exponentially by 2025, registering approximately 6.3% CAGR during the review period (2019 – 2025). Increasing uses of contrast media in medical imaging to enhance the visibility of blood vessels & GI tract support the growth of the market. Moreover, rising numbers of contrast media approvals act as a key tailwind pushing the market forward. Simultaneously, the rising expectations of radiologists augment market demand.

 Free Sample report At:

https://www.marketresearchfuture.com/sample_request/1284

 Additionally, the rising prevalence of various chronic diseases such as GIT, cancer, cardiac conditions, and an increase in the number of public as well as private diagnostic centers are fostering market growth. Also, the demand for improved diagnostic imaging services and various diagnostic imaging modalities are creating substantial market demand. On the flip side, the risk of side / adverse effects of the contrast media is impeding the market growth. However, technological innovations would support the contrast media market growth, improving media functionalities.

 Global Contrast Media Market – Segments

The analysis has been segmented into six main dynamics.

By Type                      : Iodinated Contrast Media and Gadolinium-Based Contrast Media, and others.

By Form                     : Tablet, Powder, Liquid, and Paste.

By Procedure : Computed Tomography, X-ray, Ultrasound, Magnetic Resonance Imaging, and other procedures.

By Application           : Oncology, Cardiovascular Disorders, Nephrological Disorders, and others.

By Route of Administration  : Injectable, Oral, and Rectal.

By Regions             : Asia Pacific, North America, Europe, and the Rest-of-the-World.

 Global Contrast Media Market – Geographical Analysis

North America dominates the global contrast media market. The largest market share majorly attributes to the advancements in the medical & imaging technologies. Furthermore, the increasing prevalence of chronic diseases and massive uptake of advanced technologies for the diagnosis of myriad diseases & disorders drive the regional market growth. The presence of notable players and their increasing emphasis on delivering cost-competitive product range foster the growth of the contrast media market in the region.

Europe accounts for the second-largest market share in the global contrast media market. Increasing healthcare expenditures and the adoption of advanced technologies boost regional market growth. Also, the presence of many global players in the region is another key driving the growth of the regional market. Additionally, the growth of the medical supplies market in the region fosters the European contrast media market.

The Asia Pacific region is becoming a profitable market for Contrast Medias, globally. Factors such as the rapidly increasing healthcare sectors and developing economy in the region are pushing the growth of the market. Besides, profusely developing APAC countries such as India, Japan, and China, contribute to the regional market growth, significantly. Also, the rising population and spreading awareness for the functionalities of contrast media influence the market growth in the APAC region.

 Global Contrast Media Market – Competitive Analysis

The market appears highly competitive and diversified with the presence of several well-established players. To gain a larger competitive advantage in the market, players adopt strategies such as mergers & acquisitions, expansion, collaboration, and product & technology launch. They make substantial R&D investments in developing new products and manufacturing technology. 

 Major Players: 

Players active in the global contrast media market include NanoScan Imaging (US), Bayer Healthcare Pharmaceuticals (Germany), Daiichi (Japan), Medrad Inc. (US), Guerbet Group (France), Subhra Pharma Private Limited (India), GE Healthcare (US), nanoPET Pharma GmbH (Germany), Covidien (Ireland), AMAG Pharmaceuticals (US), CMC Contrast AB (Sweden), Targeson (US), Mallinckrodt Pharmaceuticals (UK), Lantheus Medical Imaging (US), and Bracco Diagnostic Inc. (Italy), among others. 

 Industry, Innovation & Related News 

November 04, 2019 --- GE Healthcare (the US), a multinational conglomerate leader in providing diagnostic imaging agents, announced receiving the US FDA approval for its macrocyclic MRI contrast agent Clariscan. The approval expands the GE Healthcare portfolio for US patients and radiologists. 

Gadolinium-based contrast agent, Clariscan is indicated for intravenous use with MRI in the brain (intracranial), spine, and associated tissues in adult & pediatric patients to detect and visualize areas with disruption of the blood-brain barrier (BBB) and/or abnormal vascularity.

 Browser Full Report At:

https://www.marketresearchfuture.com/reports/contrast-media-market-1284

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

 About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

[renojobshub]

IT Director

Healthcare Information Technology IT Director

IT Director will support multiple locations

Healthcare IT experience preferred

A rare opportunity for an experienced Healthcare IT professional is now available with an area leading healthcare organization. The IT Director will work with a privately owned company that offers diagnostic imaging in the form of: CT, DXA, MRI, Nuclear Medicine, PET/CT, Ultrasound, X-Ray Diagnostic Fluoroscopy, Women’s Imaging Services, and 3D Mammography. 

The IT Director will support three medical office locations that are within 30 minutes of each other. Travel may be required throughout the region but will be limited. Familiarity of healthcare compliance including HIPPA privacy laws will aid in a smooth transition into this IT Director role. Additional experience in electronic medical records or electronic health records is also a plus. 

Portland Oregon will become the company’s 3rd branch location and will readily connect into the national CMC recruitment network. Led by a veteran CMC recruiter, this expansion effort is expected to come together quickly pacing for a November 2018 launch.

For the 3rd year in a row, Clinical Management Consultants has earned distinction as one of America’s fastest growing companies.

Clinical Management Consultants to release a revamped software platform built for Healthcare Recruitment. The modernized applicant tracking system will be released later this year.

Detailed information of the proposed Tax Cuts and Jobs Act 11/2017

CMC East Coast Office, located in Cleveland, Ohio, is excited to announce their relocation this summer to Cleveland’s fast-growing, trendy neighborhood of the Flats East Bank. CMC will move into the Old Sammy’s Building, now called Settler’s Point, located on West 10th Street.

Clinical Management Consultants provides Healthcare Recruitment to Acute Care Hospitals and Healthcare Companies across the US. CMC offers Contingency Recruitment, Healthcare Interim Management, Executive Search, Nurse Recruitment Software and Strategic Hospital Management Consulting Services.

from Reno Jobs Hub https://ift.tt/36na6RL via IT Director

[market-research-repoert]

Industry analysis provides a company with an understanding of its position relative to other companies in the industry. This can help them identify opportunities and potential threats, so they can prepare for the present and future. MRI Research helps organizations to figure out whats happening in a given industry, including demand and supply statistics, degree of competition, state of competition with other emerging industries, future prospects considering technological changes, and external factors on the industry.

[market-research-future]

Contrast Media Market Trend Analysis | Supply and Segmentation | Forecast To 2025

Market Research Future published a half-cooked research report on “Global Contrast Media Market Research Report - Forecast to 2025” – Market Analysis, Scope, Stake, Progress and Trends.

Contrast Media Market Research Report: By Type (Iodinated Contrast Media and Gadolinium-Based Contrast Media), by Form (Tablet, Powder, Liquid and Paste), Procedures (X-ray/Computed Tomography (CT) and Magnetic Resonance Imaging (MRI)), By Application (Cardiovascular Disease, Oncology and Gastrointestinal Disorders), By Route of Administration (Rectal, Oral and Injectable) and Region (the Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2025

Global Contrast Media Market   - Overview

The market is forecasted to demonstrate a neutral growth by 2023, global contrast media market size is expected to grow at a CAGR of 6.3 % during forecast period of 2017-2023. Contrast media are substances which are utilized to improve the contrast of fluids in the body during medical imaging. It is basically used to enhance the visibility of blood vessels and GI tract. The global contrast media market is growing with the steady pace; mainly due to the increasing prevalence of different diseases such as GIT diseases and cardiac diseases. According to a recent study report published by the Market Research Future, the global contrast media market is expected to gain prominence over the forecast period.

The market is going to continue with the same trends of growth during the forecast period. The major factors influencing the growth of the market include increasing technology advancement in contrast medium, increasing prevalence of cancer and cardiac diseases, growth in emerging markets for imaging technology, increasing demand for diagnostics, and image guide procedures and various others. Whereas, the risk of side effects and adverse effects of the contrast media may hamper the growth of the market.  

Global Contrast Media Market Competitive Analysis

Characterized by the presence of several well-established and small players, the global market of contrast media appears to be highly competitive and fragmented. With well-established market in the North America region major companies like GE Healthcare, AMAG Pharmaceuticals, NanoScan Imaging   have their home in the region and generate maximum market share. These companies have expanded their operating unit in various other emerging regions as well. Moreover, the other small and medium scale players are generating revenue from local market.

GE Healthcare an American multinational company headquartered in the U.S., is one of the leading players in the contrast medium market with manufacturing and distribution of diagnostic imaging agents with more than 100 countries. OMNISCAN and VISIPAQUE are the major products of the company. Recently in March 2017, the company showcased its MRI contrast media product range at the European Congress of Radiology (ECR) 2017 meeting by launching Clariscan, which is a macrocyclic agent and is a gadolinium-based contrast agent (GBCA).

Clariscan is intended to support effective visualisation of abnormalities in the brain, spine, and associated tissues. The launch of this product will be provided alongside GE Healthcare’s comprehensive support services and solutions to healthcare physicians across the globe. The demand for contrast media has altogether expanded over the previous decade because of increasing advancement in procedures in MR imaging, raising the significance of uninterrupted and sustainable product supply, and in addition meeting the individual needs of patients undergoing diagnostic techniques. Knowing the demand for contrast medium, GE healthcare invested over USD 65 million in its overall supply across the globe from 2013 and 2016, to increase its manufacturing capacity. GE contrast media products are utilized as a part of more than 70 million systems for every year, identical to infusion in two patients for each second. In 2015, 62 million patients diagnosed using GE contrast media and acquired major share for the global contrast media industry.

Furthermore, Daiichi a global pharmaceutical company and the second largest pharmaceutical company headquartered in Japan. Sonazoid an ultrasound contrast medium is widely used product of the company. In 2014, company has acquired Ambit Biosciences.

Bayer Healthcare Pharmaceuticals Inc. is headquartered in Germany. It is a multinational chemical, pharmaceutical, and life sciences company. In April 2016, the company announced the approval of, Gadavist injection that is the first contrast agent used with magnetic resonance angiography. Gadavist MRA significantly improved the visualization or assess ability when compared to unenhanced MRA. This approval of the advanced product will enhance the revenue growth which will further boost the growth of the market. Ultravist, Eovist and Magnevist are the some of the major products of the company.GE Healthcare (US), Daiichi (Japan), Bayer Healthcare Pharmaceuticals (Germany), AMAG Pharmaceuticals (US), NanoScan Imaging (US), Medrad Inc (US), Targeson (US), Guerbet (Japan), Bracco Diagnostic Inc. (Italy), Guerbet Group (France), Covidien (Ireland), Lantheus Medical Imaging (U.S.), Bracco Imaging S.p.A. (Italy), Subhra Pharma Private Limited (India), nanoPET Pharma GmbH (Germany), CMC Contrast AB (Sweden), Mallinckrodt Pharmaceuticals (UK) are some of the prominent players at the forefront of competition in the Global Contrast Media Market and are profiled in MRFR Analysis.

Brows More Medical Devices Related Market Research Reports:

Dermatology Diagnostic Devices Market Applications, Share | Size Analysis, 2022

Crohn’s Disease Market share, Trends | Growth Analysis, 2025

Pregnancy Test Kits Market Size, Trends Analysis | Growth, 2023

About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact

Market Research Future  

Office No. 528,  

Amanora Chambers Magarpatta Road,  

Hadapsar,  

Pune - 411028  

Maharashtra,

India  

+1 646 845 9312  

Email: sales@marketresearchfuture.com

[isiawgr-blog]

Global Contrast Media Market Challenges, Growth and Geographical Segmentation by 2023

Global Contrast Media Market - Insights

Contrast Media substances or agents assist in increasing the contrast of structures or fluids of the body during medical imaging. They enhance the visibility of blood vessels. The Global Contrast Media Market is anticipated to grow at a CAGR of 6.3% during the assessment period of 2017-2023, asserts Market Research Future (MRFR) in a detailed research report.

Rising prevalence of various chronic diseases, increasing burden of cancer, and hike in mortality rates on a global scale which generates high demand for diagnosis and image-guided procedures. Contrast media finds application in diverse modalities such as ultrasound, MRI scans, x-rays and in cath lab procedures.

Unlike x-rays, contrast agents are associated with fewer adverse drug reactions. The favorable safety profile of contrast media makes them the preferred choice for medical imaging purposes as they can even be used to diagnose pregnant women without any side effects. Rise in a number of approvals for innovative and advanced contrast media by FDA and other administrative bodies coupled with growth in the number of diagnostic centers across the globe has spurred the market growth of contrast media.

Advancement in contrast agents and technical capabilities of medical imaging has inflated the accuracy of medical imaging procedures which further fuels the growth of the market. Other driving factors include growth in global geriatric population, increasing R&D activities and government funding. However, the growth of the market might be dampened by the economic slowdown in various economies and side effects associated with contrast media.

Global Contrast Media Market - Key Players

GE Healthcare (US), Daiichi (Japan), Bayer Healthcare Pharmaceuticals (Germany), AMAG Pharmaceuticals (US), NanoScan Imaging (US), Medrad Inc (US), Targeson (US), Guerbet (Japan), Bracco Diagnostic Inc. (Italy), Guerbet Group (France), Covidien (Ireland), Lantheus Medical Imaging (U.S.), ), Bracco Imaging S.p.A. (Italy), Subhra Pharma Private Limited (India), nanoPET Pharma GmbH (Germany), CMC Contrast AB (Sweden), Mallinckrodt Pharmaceuticals (UK)

Browse Complete 80 Pages Premium Research Report Enabled with Tables and Figures @ https://www.marketresearchfuture.com/reports/contrast-media-market-1284

Competitive Analysis:

GE Healthcare an American multinational company headquartered in the U.S., is one of the leading players in the contrast medium market with manufacturing and distribution of diagnostic imaging agents with more than 100 countries. OMNISCAN and VISIPAQUE are the major products of the company. Recently in March 2017, the company showcased its MRI contrast media product range at the European Congress of Radiology (ECR) 2017 meeting by launching Clariscan, which is a macrocyclic agent and is a gadolinium-based contrast agent (GBCA). Clariscan is intended to support effective visualization of abnormalities in the brain, spine, and associated tissues. The launch of this product will be provided alongside GE Healthcare’s comprehensive support services and solutions to healthcare physicians across the globe. The demand for contrast media has altogether expanded over the previous decade because of increasing advancement in procedures in MR imaging, raising the significance of uninterrupted and sustainable product supply, and in addition meeting the individual needs of patients undergoing diagnostic techniques. Knowing the demand for contrast medium, GE healthcare invested over USD 65 million in its overall supply across the globe from 2013 and 2016, to increase its manufacturing capacity. GE contrast media products are utilized as a part of more than 70 million systems for every year, identical to infusion in two patients for each second. In 2015, 62 million patients diagnosed using GE contrast media and acquired major share for the global contrast media market.

Daiichi a global pharmaceutical company and the second largest pharmaceutical company headquartered in Japan. Sonazoid an ultrasound contrast medium is widely used product of the company. In 2014, company has acquired Ambit Biosciences.

Bayer Healthcare Pharmaceuticals Inc. is headquartered in Germany. It is a multinational chemical, pharmaceutical, and life sciences company. In April 2016, the company announced the approval of, Gadavist injection that is the first contrast agent used with magnetic resonance angiography. Gadavist MRA significantly improved the visualization, or assess ability when compared to unenhanced MRA. This approval of the advanced product will enhance the revenue growth which will further boost the growth of the market. Ultravist, Eovist and Magnevist are the some of the major products of the company.

Industry News:

In November 2018, the U.S. Food and Drug Administration (FDA) approved the clinical use of a magnetic resonance imaging (MRI) scanner which allows spotting pituitary tumors in crushing's patients. The new ultra-high field 7T Terra MRI scanner allows more reliable images of the brain and facilitates identification of very small tumors which standard MRI fails to spot.

In October 2018, Israeli startup iNNOGING innovated breakthrough in sonography technology. The innovation will enable physicians to manipulate captured ultrasound video and allow virtual dynamic examination by conversion of the video clip into a 3D model without the presence of the patient.

Global Contrast Media Market - Segmentation

By type, the Market for Contrast Media has been segmented into intravenous contrast materials, iodine-based, and, other.

By procedures, the market has been segmented into X-ray, computed tomography, magnetic resonance imaging, ultrasound, and, other.

By application, the global contrast media has been segmented into X-ray, computed tomography, magnetic resonance imaging, ultrasound, and, other.

Global Contrast Media Market - Regional Analysis

On regional basis, contrast media market is dominated by North America which is followed by Europe. Presence of major players in North America and Europe and increasing prevalence of GI disease are the major factor for the growth of the market in this region. Asia Pacific is the third largest market and the fastest growing contrast media market. Rising awareness regarding product benefits among consumers and a huge population base in this region is the major factor for the growth of the market.

For More Information Visit @ https://www.medgadget.com/2018/12/contrast-media-market-segmentation-parameters-and-prospects-2018-with-global-major-companies-ge-healthcare-daiichi-bayer-healthcare-pharmaceuticals-etc-till-2023.html

 About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India +1 646 845 9312 Email: salesteam@marketresearchfuture.com

[apurvafmi-blog]

Contrast media and agent market have significantly evolved over the past century. Initially, Iodine and Barium-based agents were used by radiologists and practitioners, now gold nanoparticle and radio pharmaceuticals are used. Advanced techniques such as gas micro bubble technology in gas and MRI imaging technology will prove as an essentials drivers in the wide use contrast agents.

Global contrast agent and media market is fairly mature at current stage and still have the potential to groom in coming years. Some factors supporting to the growth of this market are diagnostic imaging, image guided surgical procedures, increasing rates of cardiac and cancer disorders and advancements in diagnostic technology. U.S. is currently holding the maximum shares of this market, followed by Japan and Europe.

Request Sample Report@ https://www.persistencemarketresearch.com/samples/10750

Increasing demand for image guided procedures and diagnostics, increasing incidence and mortality of cardiac and Cancer diseases, technology advancements in medical imaging market are some of the major driving forces resulting into the growth of the market. With these economies undergoing medical reforms affecting the sales of contrast agents and economic slowdowns are some factors restraining the growth of the market. Growing investments in immature markets and advanced contrast reagents having properties of contrast media and radio pharmaceuticals are some opportunities in contrast agent market.

Contrast media and agents market is segmented on the basis of product type, route of administration, medical procedure, indication, application and geography. On the basis of product the market is segmented into Barium-based contrast media, Iodinated contrast media and Gadolinium-based contrast media. On the basis of route of administration the market is segmented into oral, injectable, rectal and ureteral. With this, on the basis of medical procedure the market is segmented into X-ray, computed tomography, magnetic resonance imaging, ultrasound and Catheterization laboratory. The indication based market segments are cardiovascular disorders, Respiratory diseases, gastrointestinal disorders and nepoherological disorders. On the basis of application the market is segmented into radiology, interventional radiology and interventional cardiology. On the basis of geography the market is segmented into North America, Europe, APAC and RoW.

Request Report TOC@ https://www.persistencemarketresearch.com/methodology/10750

Amag pharmaceuticals, Inc., Bayer healthcare pharmaceuticals, Bracco Imaging Spa, Covidien, Cmc Contrast AB, Daiichi Sankyo Co., Ltd., GE Healthcare, Genovis AB, Guerbet Group,Lantheus Medical Imaging, Inc., Nanopet Pharma GmbH., Nanoscan Imaging, LLC.,Sanochemia Pharmazeutika AG, Spago Imaging AB, Subhra Pharma Private, Ltd. and Taejoon Pharm Co., Ltd., are some of the key players in contrast media and agents market.

[niteshagrawals-blog]

Thumb Arthritis Market Shares Analysis, Key Development Strategies and Forecasts Till 2023

The Global Thumb Arthritis Market is expected to grow at an approximate CAGR of 8.1% during the forecast period. Thumb or carpometacarpal (CMC) joint arthritis is a common type of arthritis affecting the hands. In the patients with thumb arthritis, the cushion-like cartilage inside the CMC joint breaks down, causing the bones to rub against each other. Some of the common symptoms of the disease are inclusive of thumb joint pain, thumb base swelling, besides others. The prevalence of the thumb arthritis is increasing which is the major driver for the market growth. In 2016, according to a study published in the HAND (American Association for Hand Surgery) journal, the prevalence of the thumb CMC osteoarthritis was estimated to be around 8% to 12% in the general population. Moreover, growing geriatric and obese population along with the rising healthcare expenditure is estimated to boost the market growth during the forecast period. According to the World Health Organization in 2016, approximately more than 1.9 billion adults, were estimated to be overweight, accounting for 650 million obese people. Additionally, according to the World Health Organization, the world’s geriatric population is estimated to reach 2 billion by 2050 from 900 million in 2015. However, the high cost of the surgical therapeutics along with related complications is estimated to restrain the market growth during the forecast period. According to a study published in the Plastic and Reconstructive Surgery journal in 2016, the cost of therapeutic trapeziectomy with LRTI for a majority of the patients (89%) was estimated to be about around USD 2,576. Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/5238 Top Players in Thumb Arthritis Market: The key players in the global thumb arthritis market are inclusive of BioPro (U.S.), McKie Splints (U.S.), AbbVie Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Amgen Inc. (U.S.), Pfizer Inc. (U.S.), Carestream Health. (U.S.), General Electric Company (U.K), and others. Market Segmentation of Thumb Arthritis Market: The global thumb arthritis market is segmented on the basis of type, diagnosis, treatment, and end user. On the basis of the type, the market is segmented into osteoarthritis thumb arthritis, rheumatoid thumb arthritis, and others. On the basis of the diagnosis, the market is segmented into physical examinations, imaging, fine needle aspiration (FNA), and others. The imaging segment is sub-segmented into X-ray, computed tomography (CT), magnetic resonance imaging (MRI), and others. On the basis of the treatment, the market is segmented into thumb exercise, medication, surgery, and others. The medication segment is sub-segmented into OCT medications, prescription medications, and others. The surgery segment is sub-segmented into trapeziectomy, osteotomy, and others. On the basis of the end users, the market is segmented into hospitals & clinics, research organizations, retail pharmacies, and others. Regional Analysis of Thumb Arthritis Market: The Americas dominate the global thumb arthritis market. A well-developed healthcare sector, growing geriatric population, and increasing healthcare expenditure are the major drivers for the growth of the global thumb arthritis market. Europe holds the second largest thumb arthritis market owing to the availability of the funds for research, increasing surgery adoption rates, and growing patient population. According to the Office for National Statistics the geriatric population within the region is expected to grow and reach 20.5% of the total U.K population by 2026 from 18.0% in 2016. Asia Pacific is the fastest growing region. Growing geriatric and obese population followed by the developing healthcare sector are boosting the market growth. Within the region, Australia holds a significant ratio of the obese population. However, the presence of the developing economies like India and China are marked by expanding healthcare sector. This is estimated to provide favorable backgrounds for the market growth. The Middle East and Africa region account for the least market share. This is mainly due to the presence of the poor African economies within the region, which have low per capita income and lack of the medical services. On the other, the Middle East holds the largest market share within the region. Browse Complete Report @ https://www.marketresearchfuture.com/reports/thumb-arthritis-market-5238 Some of Major Table of Content for Thumb Arthritis Market: Chapter 1. Report Prologue Chapter 2. Market Introduction 2.1 Definition 2.2 Scope of The Study 2.2.1 Research Objective 2.2.2 Assumptions 2.2.3 Limitations Chapter 3. Research Methodology 3.1 Introduction 3.2 Primary Research 3.3 Secondary Research 3.4 Market Size Estimation Chapter 4. Market Dynamics 4.1 Drivers 4.2 Restrains 4.3 Opportunities 4.4 Challenges 4.5 Macroeconomic Indicators 4.6 Technology Trends & Assessment 4.5 Macroeconomic Indicators TOC Continued….! ​ Get Discount @ https://www.marketresearchfuture.com/check-discount/5238 About US: Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact Us: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India Phone: +1 646 845 9312 Email: sales@marketresearchfuture.com